Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml

Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence

Novel Mycobacterium tuberculosis growth inhibitor

Novel microtubule-stablizer

K+ channel blocker

Novel TLR7 agonist via immune response induction and tumor microenvironment modulation

Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD

Novel COX-2 inhibitor

Potent and selective CCKA receptor antagonist

Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile

Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

Type-A trichothecene mycotoxin

Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)

Novel Inhibitor of Adenovirus Gene Transfer

Novel Inhibitor of Adenovirus Gene Transfer

Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein

Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems

Natural radical scavenger on ABTS

Novel Inhibitor of Parasite Motility and Invasion

Novel Inhibitor of Parasite Motility and Invasion

Novel Irriversible Inhibitor of Parasite Motility and Invasion